Overcoming Fear of Public Speaking with "The Art of Laughter" - Insights
Nhien Chau, Clinical Laboratory Technologist in the Biochemical Genetics Laboratory at Mayo Clinic, decided to face his fear of public speaking by joining the Rochester Chamber Toastmasters group.
What Are MLS Students Learning in Hematology? - Insights
Rachel Olk, a student in the Mayo Clinic Medical Laboratory Science class of 2018, writes about what she's currently learning in hematology.
Hunting Accident Leads to Memorable Mayo Experience #ThrowbackThursday - Insights
This story was told by Gary and Virginia Chalberg of Kingman, Arizona, who were visiting family at Mayo Clinic Hospital in Phoenix. While there, Gary, 84, asked if he could share the story of his dad’s first patient experience at Mayo...
Mayo Clinic Laboratory and pathology research roundup: January 25 - Insights
Today's Topic Features: Measurable residual disease does not preclude prolonged progression-free survival in CLL treated with ibrutinib.
Assay enhances and simplifies M-proteins screening: David Murray, M.D., Ph.D. - Insights
David Murray, M.D., Ph.D., explains how Mayo Clinic Laboratories' MASS-FIX Quantitation assay provides next-generation screening for M-proteins, which are associated with multiple myeloma and other diseases. The assay better quantitates the...
Paul Jannetto, Ph.D., explains the advantages that Mayo Clinic Laboratories' oral fluid drug screening offers over typical urine tests. Oral samples are easier to collect and harder to adulterate.
Clinical and forensic toxicology - Insights
Clinical, forensic, and emergency toxicology testing at Mayo Clinic Laboratories, which aligns with evidence-based clinical laboratory guidelines, uses advanced and emerging technologies and is performed on urine, serum, and meconium...
Antibody against the GABA-A receptor is a biomarker of autoimmune encephalopathy that occurs across the lifespan, and disproportionately affects children. In this test-specific episode of the "Answers From the Lab" podcast, Andrew McKeon,...
Patients with elevated LDL or "bad" cholesterol face even greater risk if their levels of small dense LDL cholesterol are also high. Vlad Vasile, M.D., Ph.D., and Leslie Donato, Ph.D., explain how Mayo Clinic Laboratories' sdLDL-c assay...
Genetic Tests Identify Risk of Fluoropyrimidine-Induced Toxicity: Ann Moyer, M.D., Ph.D. - Insights
Ann Moyer, M.D., Ph.D., explains how Mayo Clinic Laboratories' unique genetic tests identify patients at high risk of severe reactions to fluoropyrimidines — a type of chemotherapy drug. Test results can guide clinical decision-making for...